Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer

6 Aug 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Clusterin in disease pathology
Share to Ferroptosis and cancer prognosis

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39243601
DOI: 10.1016/j.drup.2024.101126

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancerPMID 39243601Read ↗

Taraxerol induces ferroptosis in breast cancer by targeting Nrf2 transcriptional activity to promote MIB2-mediated GPX4 ubiquitinationSemantic proximity Read ↗

CtBP Promoted P4HB Mediates SLC7A11 Maturation to Confer Ferroptosis Resistance in Triple-Negative Breast CancerSemantic proximity Read ↗

Targeting ferroptosis: a promising strategy to overcome drug resistance in breast cancerSemantic proximity Read ↗

HSPB1 as a novel regulator of ferroptotic cancer cell deathSemantic proximity Read ↗

TFAP2C/FLT3 axis reduces ferroptosis in breast cancer cells by inhibiting mitochondrial autophagySemantic proximity Read ↗

CRISPR/Cas9-mediated knockout of Lcn2 in human breast cancer cell line MDA-MB-231 ameliorates erastin-mediated ferroptosis and increases cisplatin vulnerabilitySemantic proximity Read ↗

Ferroptosis resistance in cancer: recent advances and future perspectivesSemantic proximity Read ↗

N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancerSemantic proximity Read ↗

BRCA1-Mediated Dual Regulation of Ferroptosis Exposes a Vulnerability to GPX4 and PARP Co-Inhibition in BRCA1 -Deficient CancersSemantic proximity Read ↗

DNAJC12 causes breast cancer chemotherapy resistance by repressing doxorubicin-induced ferroptosis and apoptosis via activation of AKTSemantic proximity Read ↗

Targeting protein quality control pathways in breast cancerSemantic proximity Read ↗

Targeting ferroptosis resistance resensitizes metastatic HR + HER2 − breast cancer cells to palbociclib‐hormone therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.